LOS ANGELES, CA / ACCESSWIRE / July 21, 2016 / Lundin Law PC (the "Firm") announces a class action lawsuit has been filed against Endo International plc ("Endo" or the "Company") (NASDAQ: ENDP) concerning possible violations of federal securities laws between March 2, 2015 and May 6, 2016 (the "Class Period"). Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 25, 2016 lead plaintiff motion deadline.

To participate in this class action lawsuit, click here. You can also call Brian Lundin, Esquire, of Lundin Law PC, at 888-713-1033, or e-mail him at brian@lundinlawpc.com.

No class has been certified in the above action. Until a class is certified, you are not considered represented by an attorney. You may also choose to do nothing and be an absent class member.

According to the complaint, the Company failed to disclose that its arrangements with pharmacy benefit managers with respect to the migraine therapy Frova included questionable incentives intended to raise sales revenues, and as a result, Endo's revenues and revenue projections relied in part on unsustainable arrangements. When this news was announced, shares of Endo dropped in value.

Lundin Law PC was created by Brian Lundin, a securities litigator based in Los Angeles.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contact:

Lundin Law PC
Brian Lundin, Esq.
Telephone: 888-713-1033
Facsimile: 888-713-1125
brian@lundinlawpc.com
http://lundinlawpc.com/

SOURCE: Lundin Law PC